Ann: Dr Irminger steps down from Board, continues as Consultant, page-7

I suspect there may have been some 'serious division' at the 'new' BD1 board-level on who/what is the 'driver' for BD1 moving forward, ex-Sienna reps all would be 'passionate' about their prior work/achievements, 1x product (H-TERT) 'in market', which is ahead of the BD1 product/s, so I'm sure they get 'cocky' about where 'limited' CAPEX should go, thinking they're somewhat 'entitled' because it's their product helping to fund future-endeavours (BD1)...

If the BD1 stream is successful and granted approvals (FDA,, TGA, etc), it's likely to become the new 'standard' (like PSA-bloods for prostate, etc), which is a game changer, hopefully they realise that, a few $$$ doesn't make you 'Fat Tony' when Jeff Bezos turns up, he gets washed-up, and a mass-exodus of capital now means 'Fat Tony' is 'dead in the water' right now rather than fading-away later...

Noticing the good-doctor's Performance Rights expire in June 2021, so I imagine the 'pressure is on' to get some traction, then 're-steer' the ship back onto conquering oceans, not ponds, will be a massive shame if the BD1 product dies of CAPEX-starvation because of an ego...

I'm considering an email to CEO to question strategy (perhaps it's a forced majeure) and raise a level of concern, I bought into BD1 for the one and only BD1 product, the good-doctor IF...